Market revenue in 2023 | USD 2,521.4 million |
Market revenue in 2030 | USD 4,075.7 million |
Growth rate | 7.1% (CAGR from 2023 to 2030) |
Largest segment | Coronary stents |
Fastest growing segment | Accessory Devices |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Intravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.
Coronary stents was the largest segment with a revenue share of 50.34% in 2023. Horizon Databook has segmented the Europe interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.
In Europe, the market for interventional cardiology devices is thriving due to ongoing innovations, regional approval of newer technologies, such as next-generation DES & BRS, and subsequent acceptance of these expensive technologies due to their benefits in revascularization treatments.
In addition, there are many ongoing initiatives for reduction of CVD burden in the region. For instance, in May 2023, the European Society of Cardiology collaborated with Europa Group and PCR to reduce the global prevalence of CVDs.
In May 2023, Canon Medical joined an advanced course in interventional cardiovascular medicine at the EuroPCR conference in France to learn about the latest dose-reduction devices & tools and cutting-edge technologies.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe interventional cardiology devices market , including forecasts for subscribers. This continent databook contains high-level insights into Europe interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account